Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.

Source:http://linkedlifedata.com/resource/pubmed/id/15380859

Download in:

View as

General Info

PMID
15380859